In this review, we highlight recent discoveries regarding mechanisms contributing to nerve-
cancer cross-talk and the effects of nerve-cancer cross-talk on tumor progression and …

Simple Summary Early-stage and castration-sensitive prostate cancer (PCa) growth is solely
mediated by androgen signaling pathways. AR signaling inhibitors (ARSIs) have …

Simple Summary Prostate cancer can develop under hormone treatment and chemotherapy
from a castration-sensitive towards a castration-resistant into a drug resistant-tumor. The …

Breast cancer (BC) is still characterized by high morbidity and mortality. A specific BC
subtype named triple negative BC (TNBC) lacks estrogen and progesterone receptors (ER …

A major challenge in clinical management of prostate cancer (PC) is to limit tumor growth
and prevent metastatic spreading. Considerable efforts have been made to discover new …

Prostate cancer represents the major cause of cancer-related death in men and patients
frequently develop drug-resistance and metastatic disease. Most studies focus on hormone …

Prostate cancer (PC) represents the most diagnosed and the second most lethal cancer in
men worldwide. Its development and progression occur in concert with alterations in the …

In the last decade, three-dimensional (3D) cell culture technology has gained a lot of interest
due to its ability to better recapitulate the in vivo organization and microenvironment of in …

Prediction of prostate cancer in primary care is typically based upon serum total prostate-
specific antigen (tPSA) and digital rectal examination results. However, these tests lack …

Resistance to hormone therapy and disease progression is the major challenge in clinical
management of prostate cancer (PC). Drugs currently used in PC therapy initially show a …